ResMed Inc. (BMV:RMD)

Market Cap	770.42B
Revenue (ttm)	97.05B
Net Income (ttm)	26.42B
Shares Out	n/a
EPS (ttm)	179.34
PE Ratio	29.17
Forward PE	25.95
Dividend	41.98 (0.81%)
Ex-Dividend Date	May 8, 2025

Volume	n/a
Average Volume	33
Open	5,196.59
Previous Close	5,196.59
Day's Range	5,196.59 - 5,196.59
52-Week Range	3,836.00 - 5,205.10
Beta	n/a
RSI	97.62
Earnings Date	Jul 31, 2025

About Landsea Homes

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on de...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1989
• Employees: 9,980
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: RMD

Financial Performance

In 2025, ResMed's revenue was $5.15 billion, an increase of 9.84% compared to the previous year's $4.69 billion. Earnings were $1.40 billion, an increase of 37.20%.